INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022

Rhea-AI Summary

INOVIO (NASDAQ: INO) announced it will release its third quarter 2022 financial results on November 8, 2022, post-market close. Following the announcement, the company will host a live conference call and webcast at 4:30 p.m. ET to discuss the results and provide a general business update. Interested parties can access the live and archived audio presentation via their investor relations page. INOVIO focuses on developing DNA medicines for infectious diseases, cancer, and HPV-related conditions.

Positive

• Scheduled Q3 2022 earnings release and conference call indicates transparency and shareholder engagement.

Negative

• None.

PLYMOUTH MEETING, Pa., Oct. 25, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, announced today that third quarter 2022 financial results will be released after the market close on November 8, 2022. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

A live and archived version of the audio presentation will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from infectious diseases, cancer, and diseases associated with HPV. Our DNA medicines in development are delivered using our investigational proprietary smart device to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.

Contacts

Investors & Media:
Gene Kim, (267) 589-9471, gene.kim@inovio.com
Thomas Hong, (267) 440-4298, thomas.hong@inovio.com

 

View original content:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2022-financial-results-on-november-8-2022-301658101.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO release its third quarter 2022 financial results?

INOVIO will release its third quarter 2022 financial results on November 8, 2022.

What time is the INOVIO Q3 2022 earnings call?

The earnings call for INOVIO's Q3 2022 results will be held at 4:30 p.m. ET on November 8, 2022.

How can I listen to INOVIO's Q3 2022 earnings call?

You can listen to INOVIO's Q3 2022 earnings call live and in an archived version on their investor relations website.

What is INOVIO's focus in biotechnology?

INOVIO focuses on developing and commercializing DNA medicines for infectious diseases, cancer, and diseases associated with HPV.